Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2651
Perdoceo Education
PRDO
$1.8B
| $1.76M | ﹤0.01% |
57,009
+11,259
| +25% | +$368K |
2022 Q1
18 quarters
|
|
2652
PUT
Baidu
BIDU
$26.4B
| $1.76M | ﹤0.01% |
20,300
+10,300
| +103% | +$1.04M |
2025 Q3
4 quarters
|
|
2653
Mueller Water Products
MWA
$3.77B
| $1.76M | ﹤0.01% |
82,716
+57,227
| +225% | +$1.4M |
2016 Q2
41 quarters
|
|
2654
Diversified Healthcare Trust
DHC
$1.75B
| $1.76M | ﹤0.01% |
223,619
+150,787
| +207% | +$1.27M |
2022 Q1
18 quarters
|
|
2655
Marex Group Limited Ordinary Shares
MRX
$5.33B
| $1.75M | ﹤0.01% |
25,146
+15,550
| +162% | +$1.07M |
2025 Q1
6 quarters
|
|
2656
Anavex Life Sciences
AVXL
$94.6M
| $1.75M | ﹤0.01% |
868,259
+114,033
| +15% | +$315K |
2021 Q4
19 quarters
|
|
2657
Richtech Robotics
RR
$200M
| $1.75M | ﹤0.01% |
1,109,885
+94,228
| +9% | +$159K |
2025 Q2
5 quarters
|
|
2658
Spectrum Brands
SPB
$2.1B
| $1.75M | ﹤0.01% |
22,002
+16,781
| +321% | +$1.46M |
2015 Q2
45 quarters
|
|
2659
Construction Partners
ROAD
$4.7B
| $1.75M | ﹤0.01% |
19,398
+343
| +2% | +$35.7K |
2019 Q2
29 quarters
|
|
2660
CALL
Regeneron Pharmaceuticals
REGN
$98.9B
| $1.74M | ﹤0.01% |
+2,300
| New | +$1.74M |
2026 Q3
0 quarters
|
|
2661
PUT
Circle Internet Group
CRCL
$16.4B
| $1.74M | ﹤0.01% |
21,200
-154,300
| -88% | -$11.9M |
2026 Q1
2 quarters
|
|
2662
ePlus
PLUS
$2.56B
| $1.74M | ﹤0.01% |
19,319
+6,767
| +54% | +$603K |
2013 Q2
53 quarters
|
|
2663
Spire Global
SPIR
$367M
| $1.74M | ﹤0.01% |
155,240
+147,014
| +1,787% | +$1.91M |
2024 Q2
9 quarters
|
|
2664
Robert Half
RHI
$4.35B
| $1.74M | ﹤0.01% |
47,215
-182,378
| -79% | -$7.21M |
2013 Q2
53 quarters
|
|
2665
XP
XP
$7.58B
| $1.73M | ﹤0.01% |
82,485
-135,789
| -62% | -$2.41M |
2022 Q1
18 quarters
|
|
2666
Remitly
RELY
$4.83B
| $1.73M | ﹤0.01% |
81,062
-316,552
| -80% | -$7.56M |
2022 Q1
18 quarters
|
|
2667
Dorian LPG
LPG
$2.03B
| $1.73M | ﹤0.01% |
31,409
+25,729
| +453% | +$1.23M |
2014 Q2
49 quarters
|
|
2668
CALL
Celldex Therapeutics
CLDX
$2.3B
| $1.73M | ﹤0.01% |
+53,300
| New | +$2.04M |
2026 Q3
0 quarters
|
|
2669
Tango Therapeutics
TNGX
$4.09B
| $1.72M | ﹤0.01% |
69,103
+15,341
| +29% | +$399K |
2022 Q1
18 quarters
|
|
2670
CALL
Fiverr
FVRR
$289M
| $1.72M | ﹤0.01% |
+200,000
| New | +$1.93M |
2026 Q3
0 quarters
|
|
|
2671
PUT
Fiverr
FVRR
$289M
| $1.72M | ﹤0.01% |
+200,000
| New | +$1.93M |
2026 Q3
0 quarters
|
|
2672
Edgewell Personal Care
EPC
$1.35B
| $1.72M | ﹤0.01% |
63,621
+54,224
| +577% | +$1.51M |
2013 Q2
53 quarters
|
|
2673
Blue Owl Technology Finance Corp
OTF
$4.31B
| $1.71M | ﹤0.01% |
174,698
+167,204
| +2,231% | +$1.79M |
2026 Q1
2 quarters
|
|
2674
Equity Bancshares
EQBK
$1.01B
| $1.71M | ﹤0.01% |
36,353
+19
| +0.1% | +$947 |
2016 Q3
40 quarters
|
|
2675
Controladora Vuela Compania de Aviacion
VLRS
$981M
| $1.71M | ﹤0.01% |
261,118
-2,649
| -1% | -$19.7K |
2025 Q4
3 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.